Abstract
Several oncogenes are thought to cause transformation by affecting the signal transmission pathway of growth factors. One example is the induction of c-myc, the cellular homologue of the avian transforming oncogene v-myc, by platelet-derived growth factor (PDGF)among a set of genes associated with competence induction in fibroblasts1,2. Another of the competence genes, r-fos, has been shown to be related to v-fos, the transforming gene of the FBJ sarcoma virus3. In addition, PDGF induces c-fos, the cellular homologue of v-fos4–6. The importance of c-myc induction is suggested by the observation that c-myc, under the control of a glucocorticoid regulator, can partially relieve the requirement of fibroblasts for PDGF7. We have examined the effects of oncogenes on haematopoietic/lymphoid cell differentiation, immortalization and factor dependence for growth. Here we report the effects of recombinant murine retroviruses capable of expressing the avian v-myc. With interleukin-3 (IL-3)- or interleukin-2 (IL-2)-dependent cells, the viruses abrogated the requirement for growth factors and suppressed c-myc expression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Cochran, B. H., Reffel, A. C. & Stiles, C. D. Cell 33, 939–947 (1983).
Kelly, K., Cochran, B. H., Stiles, C. D. & Leder, P. Cell 35, 603–610 (1983).
Cochran, B. H., Zullo, J., Verma, I. & Stiles, C. D. Science 226, 1080–1084 (1984).
Muller, R., Bravo, R. & Burckhardt, J. Nature 312, 20–27 (1984).
Greenberg, M. E. & Ziff, E. B. Nature 311, 433–438 (1984).
Kruijer, W., Cooper, J., Hunter, T. & Verma, I. M. Nature 312, 711–716 (1984).
Armelin, H. A. et al. Nature 310, 655–660 (1984).
Smith, K. A. Immun. Rev. 51, 337–357 (1980).
Ihle, J. N. Contemp. Topics molec. Immun. 10, 93–119 (1985).
Ihle, J. N. & Weinstein, Y. in Recognition and Regulation in Cell-Mediated Immunity (eds Watson J. D. & Marbrook, J.) 291–324 (Dekker, New York, in the press).
Nabholz, M. et al. Immun. Rev. 51, 125–127 (1980).
Pan, S. & Knowles, B. B. Virology 125, 1–7 (1983).
Ihle, J. N., Rein, A. & Mural, R. Adv. viral Oncology 4, 95–137 (1984).
Holmes, K. L., Palaszynski, E., Morse, H. C. III & Ihle, J. N. Proc. natn. Acad. Sci. U.S.A. (in the press).
Dexter, T. M., Garland, J., Scott, D., Scolnick, E. & Metcalf, D. J. exp. Med. 152, 1036–1047 (1980).
Greenberger, J. S., Gans, P., Davisson, P. & Moloney, W. Blood 53, 987–1001 (1979).
Ihle, J. N. et al. J. Immun. 129, 1377–1383 (1982).
Rapp, U. R., Reynolds, F. H. Jr & Stephenson, J. J. Virol. 45, 914–924 (1983).
Rapp, U. R. et al. Proc. natn. Acad. Sci. U.S.A. 80, 4218–4222 (1983).
Jansen, H. W., Patchinsky, T. & Bister, K. J. Virol. 48, 61–73 (1983).
Jansen, H. et al. Nature 307, 281–284 (1984).
Sutrave, P. et al. Nature 309, 85–88 (1984).
Lautenberger, J. A., Schultz, R. A., Garon, C. F., Tsichlis, P. N. & Papas, T. S. Proc. natn. Acad. Sci. 78, 1518–1522 (1981).
Vennstrom, B., Mascovici, C., Goodman, H. M. & Bishop, J. M. J. Virol. 39, 625–631 (1981).
Rapp, U. R. et al. Recent Results Cancer Res. 99, 221–236 (1985).
Rapp, U. R. et al. J. Virol. 55, 23–33 (1985).
Horak, I., Enjuanes, L., Lee, J. C. & Ihle, J. N. J. Virol. 37, 483–487 (1981).
Ihle, J. N., Rebar, L., Keller, J., Lee, J. C. & Hapel, A. Immun. Rev. 63, 101–128 (1981).
Ihle, J. N., Keller, J., Rein, A., Cleveland, J. & Rapp, U. Cold Spring Harb. Symp. 50, 211–219 (1985).
Rapp, U. R., Bonner, T. I. & Cleveland, J. L. in Retroviruses in Human Pathology (Humana, New Jersey, in the press).
Vennstrom, B. et al. EMBO J. 3, 3223–3230 (1984).
Celander, D. & Haseltine, W. A. Nature 312, 159–162 (1984).
Hann, S. R. & Eisenman, R. N. Molec. Cell. Biol. 4, 2486–2497 (1984).
Patchinsky, T., Walter, G. & Bister, K. Virology 136, 348–358 (1984).
Bowlin, T. L., Scott, A. N. & Ihle, J. N. J. Immun. 133, 2001–2006 (1984).
Palaszynski, E. W. & Ihle, J. N. J. Immun. 132, 1872–1878 (1984).
Leder, P. et al. Science 222, 765–771 (1983).
Bernard, O., Cory, S., Gerondakis, S., Webb, E. & Adams, J. M. EMBO J. 2, 2375–2383 (1983).
Stanton, L. W., Watt, R. & Marcu, K. B. Nature 303, 401–406 (1983).
Taub, R. et al. Cell 36, 339–348 (1984).
Rabbitts, T. H., Forster, P., Hamlyn, P. & Baer, R. Nature 309, 592–597 (1984).
Siebenlist, U., Henninghausen, L., Battey, J. & Leder, P. Cell 37, 381–391 (1984).
Keath, E. J., Caimi, P. G. & Cole, M. D. Cell 39, 339–348 (1984).
Pierce, J. H. et al. Cell 41, 685–693 (1985).
Graf, T., Ade, N. & Beug, H. Nature 275, 496–501 (1978).
Heard, J. M. et al. Molec. Cell. Biol. 4, 216–220 (1984).
Poiesz, B. J., Ruscetti, F. W., Mier, J. W., Woods, A. M. & Gallo, R. C. Proc. natn. Acad. Sci. U.S.A. 77, 6815–6819 (1980).
Hoshino, H. et al. Proc. natn. Acad. Sci. U.S.A. 80, 6061–6065 (1983).
Stringer, J. R., Holland, L. E., Swanstrom, R. I., Rivo, K. & Wagner, E. K. J. Virol. 21, 889–901 (1977).
McMaster, C. K. & Carmichael, G. G. Proc. natn. Acad. Sci. U.S.A. 74, 4835–4838 (1977).
Thomas, P. S. Proc. natn. Acad. Sci. U.S.A. 5201–5205 (1980).
Rigby, P. W. J., Drachmann, M., Rhodes, C. & Berg, P. J. molec. Biol. 133, 237–251 (1979).
Ihle, J. N., Keller, J., Henderson, L., Klein, F. & Palaszynski, E. W. J. Immun. 129, 2431–2436 (1982).
Farrar, J. J. J. Immunol. 125, 2555–2558 (1980).
Auffray, C. & Rougeon, F. Eur. J. Biochem. 107, 303–314 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rapp, U., Cleveland, J., Brightman, K. et al. Abrogation of IL-3 and IL-2 dependence by recombinant murine retroviruses expressing v-myc oncogenes. Nature 317, 434–438 (1985). https://doi.org/10.1038/317434a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/317434a0
This article is cited by
-
The v-myc oncogene
Oncogene (1999)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.